Vendor source
Reviewed 11 May 2026
Completeness Strong (75%)
VIDA Insights
VIDAVIDA Insights™ is a lung intelligence solution providing quantitative data and visualizations. VIDA's biomarkers measure lung destruction, inflammation, function and more, to aid the detection, diagnosis, treatment and tracking of all major lung diseases, including COPD, ILD and now COVID-19.
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDD
Class:
Class IIa
Verified by Health AI Register
Pathway:
510(k) cleared
Class:
Class II
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Other Articles
Relationships Between Airflow Obstruction and Quantitative CT Measurements of Emphysema, Air Trapping, and Airways in Subjects With and Without Chronic Obstructive Pulmonary Disease
Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults
Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study
Quantitative CT of Interstitial Lung Disease
SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Feb 28, 2020 | Last updated: May 11, 2026